The FDA has approved a new drug for the prevention of malaria. ARAKODA™, the brand name for Tafenoquine, will be produced in tablet form and used by those over the age of 18. Its approval presents a milestone after years of research and discovery in the antimalarial field.
A groundbreaking by Durham University shows that a new type of mosquito net has the potential to prevent millions of cases of malaria.
We often talk of a making a donation or a contribution to malaria charities. But have you ever wondered who is on the ground, carrying out this life-saving work? In this article, we reveal the charities and organisations fighting malaria in 2018.
Chinese chemist Tu Youyou slashed malaria mortality rates in Asia and Africa with her work being recently honoured with a Nobel prize in medicine. Here’s a rundown of who she is and why her work is relevant today.
Before an individual is administered Tafenoquine, they must undergo a G6PD Blood Test. These pre-screening requirements are only available to those in first world countries, meaning that Tafenoquine will be unusable in places where the burden of P. vivax malaria remains significant.
Many of us are too familiar with the bothersome buzz of a mosquito. But in a collaboration with Kew Gardens, Oxford University are putting this sound to use. Read how the ‘Humbug’ mobile app could save lives, by detecting the presence of a mosquito.
This week the FDA declared their endorsement for Tafenoquine, an anti-malaria drug developed by British pharmaceutical giant, GSK. Here’s a breakdown of what the drug does and why this news is significant.